Use of a Glass Membrane Pumping Emulsification Device Improves Systemic and Tumor Pharmacokinetics in Rabbit VX2 Liver Tumor in Transarterial Chemoembolization.

• 資料種別: 博士論文
• ISSN: 1051-0443
• タイトル: Use of a Glass Membrane Pumping Emulsification Device Improves Systemic and Tumor Pharmacokinetics in Rabbit VX2 Liver Tumor in Transarterial Chemoembolization.
• 巻次・部編番号: 31 2
• 著者・編者: Masada, Tetsuya; Tanaka, Toshihiro; Nishiofuku, Hideyuki; Fukuoka, Yasushi; Taiji, Ryosuke; Sato, Takeshi; Tatsumoto, Shota; Minamiguchi, Kiyoyuki; Marugami, Nagaaki; Kichikawa, Kimihiko
• 著者標目: Masada, Tetsuya; Tanaka, Toshihiro; Nishiofuku, Hideyuki; Fukuoka, Yasushi; Taiji, Ryosuke; Sato, Takeshi; Tatsumoto, Shota; Minamiguchi, Kiyoyuki; Marugami, Nagaaki; Kichikawa, Kimihiko
• 出版事項: Elsevier
• 出版年月日等: 2020-02; 31 2
• 出版年（W3CDTF）: 2020-02
• 並列タイトル等: 膜乳化デバイスによるエマルションを用いたウサギVX2肝腫瘍モデノレへの肝動脈化学塞栓術における抗腫瘍効果、薬物動態の検討
• タイトル（掲載誌）: Journal of vascular and interventional radiology
• 授与機関名: 奈良県立医科大学
• 授与年月日: 2019-12-05
• 授与年月日（W3CDTF）: 2019-12-05
• 報告番号: 乙第1443号
• 学位: 博士（医学）
• 博論授与番号: 乙第1443号
• 本文の言語コード: eng
• 対象利用者: 一般
• 一般注記: type:Thesis; Purpose: To evaluate the phamacokinetics of epirubicin in conventional transarterial chemoembolization using a developed pumping emulsification device with a microporous glass membrane in VX2 rabbits. Materials and methods: Epirubicin solution (10 mg/mL) was mixed with ethiodized oil (1:2 ratio) using the device or 3-way stopcock. Forty-eight rabbits with VX2 liver tumor implanted 2 weeks prior to transarterial chemoembolization were divided into 2 groups: a device group (n = 24) and a 3-way-stopcock group (n = 24). Next, 0.5 mL of emulsion was injected into the hepatic artery, followed by embolization using 100-300-μm microspheres. The serum epirubicin concentrations (immediately after, 5 minutes after, and 10 minutes after) and the tumor epirubicin concentrations (20 minutes after and 48 hours after) were measured after transarterial chemoembolization. Histopathologic evaluation was performed with a fluorescence microscope. Results: The area under the curve and maximum concentrations of epirubicin in plasma were 0.45 ± 0.18 μg min/mL and 0.13 ± 0.06 μg/mL, respectively, in the device group and 0.71 ± 0.45 μg min/mL and 0.22 ± 0.17 μg/mL, respectively, in the 3-way-stopcock group (P = .013 and P = .021, respectively). The mean epirubicin concentrations in VX2 tumors at 48 hours in the device group and the 3-way-stopcock group were 13.7 ± 6.71 and 7.72 ± 3.26 μg/g tissue, respectively (P = .013). The tumor necrosis ratios at 48 hours were 62 ± 11% in the device group and 51 ± 13% in the 3-way-stopcock group (P = .039). Conclusions: Conventional transarterial chemoembolization using the pumping emulsification device significantly improved the pharmacokinetics of epirubicin compared to the current standard technique using a 3-way stopcock.; 博士（医学）・乙第1443号・令和元年12月5日; Copyright © 2019 SIR. Published by Elsevier Inc. All rights reserved.; identifier:Journal of vascular and interventional radiology Vol.31 No.2 p.347-351 (2020 Feb); identifier:10510443; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3699; identifier:Journal of vascular and interventional radiology, 31(2): 347-351
• DOI: info:doi/10.1016/j.jvir.2019.06.015; https://doi.org/info:doi/10.1016/j.jvir.2019.06.015
• 国立国会図書館永続的識別子: info:ndljp/pid/11538417; https://dl.ndl.go.jp/pid/11538417
• コレクション（共通）: 障害者向け資料
• コレクション（障害者向け資料：レベル1）: テキストデータ
• コレクション（個別）: 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• 収集根拠: 博士論文（自動収集）
• 受理日（W3CDTF）: 2020-09-07T06:04:08+09:00
• 記録形式（IMT）: application/pdf
• オンライン閲覧公開範囲: 国立国会図書館内限定公開
• デジタル化資料送信: 図書館・個人送信対象外
• 遠隔複写可否（NDL）: 可
• 掲載誌（URI）: http://hdl.handle.net/10564/3699
• 連携機関・データベース: 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

目次

2024-05-04 再収集

2024-05-04 再収集

2024-05-04 再収集